About AbbVie Inc. (ABBV)
AbbVie Inc. is a Drug Manufacturers - General company operating in the Healthcare sector.
ABBV trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $294.89
- Market Cap
- $521.11B
- 52-Week High
- $298.74
- 52-Week Low
- $190.75
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
$1,000 Invested in AbbVie Inc. (ABBV)
How much would $1,000 invested in ABBV be worth today?
What would $1,000 invested in ABBV 1 year ago be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) in 2025 would be worth $1,331 as of November 2026, representing a +33.1% total return.
What would $1,000 invested in ABBV 3 years ago be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) in 2023 would be worth $2,244 as of November 2026, representing a +124.4% total return.
What would $1,000 invested in ABBV 5 years ago be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) in 2021 would be worth $3,246 as of November 2026, representing a +224.6% total return.
What would $1,000 invested in ABBV 10 years ago be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) in 2016 would be worth $7,268 as of November 2026, representing a +626.8% total return.
What would $1,000 invested in ABBV at IPO be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) at IPO would be worth $14,533 as of November 2026, representing a +1353.3% total return.
DCA vs Lump Sum Calculator
Compare dollar-cost averaging vs lump sum investing strategies for ABBV
ABBV vs S&P 500
See how ABBV compares to the S&P 500 benchmark over time
Monthly Returns Heatmap
Over the past 13+ years (165 months), AbbVie Inc. (ABBV) has averaged a monthly return of +1.85% with a median return of +1.70%. The stock had 103 positive months (62%) and 61 negative months (37%). The best month in ABBV's history was November 2020 with a +22.9% return, while the worst was March 2018 at -18.3%. Historically, November tends to be the strongest month (averaging +6.4%), and January the weakest (-1.7%).
ABBV's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 5 consecutive months of losses. The best full year was 2017 with a cumulative return of +49.7%, and the worst was 2015 at -3.6%.
Annual Returns
Over 13 years of trading history, AbbVie Inc. (ABBV) has delivered an average annual return of +20.04% with a median return of +24.01%. The compound annual growth rate (CAGR) is +18.71%. The stock posted gains in 10 years (77%) and losses in 3 years (23%).
ABBV's best year was 2017 with a +60.07% gain, while the worst was 2015 at -6.50%. The longest streak of consecutive positive years was 4, and the longest losing streak was 1 years. ABBV achieved double-digit gains (10%+) in 8 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +32.92% | $221.85 | $294.89 |
| 2025 | +33.08% | $166.71 | $221.85 |
| 2024 | +18.86% | $140.26 | $166.71 |
| 2023 | -0.23% | $140.59 | $140.26 |
| 2022 | +24.01% | $113.37 | $140.59 |
| 2021 | +32.43% | $85.61 | $113.37 |
| 2020 | +27.72% | $67.03 | $85.61 |
| 2019 | +1.47% | $66.06 | $67.03 |
| 2018 | -0.96% | $66.70 | $66.06 |
| 2017 | +60.07% | $41.67 | $66.70 |
| 2016 | +9.79% | $37.95 | $41.67 |
| 2015 | -6.50% | $40.59 | $37.95 |
| 2014 | +27.92% | $31.73 | $40.59 |
Frequently Asked Questions: ABBV
What sector is ABBV in? ▼
ABBV operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has ABBV performed historically? ▼
Over 13 years of trading history, ABBV has posted gains in 10 years (77% of the time). The best year was 2017 with a +60.1% return. Past performance does not guarantee future results.
How can I invest in ABBV? ▼
You can invest in ABBV through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold ABBV.
Last updated: 11/1/2026